An announcement from BridgeBio Oncology Therapeutics ( (BBOT)) is now available. On January 7, 2026, BridgeBio Oncology Therapeutics reported positive preliminary clinical data across all three of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results